/l3-Bungarotoxin consists of a phospholipase A2 subunit and a non-phospholipase A2 subunit. The toxin was oxidized with a 100-fold molar excess of chloramine T with respect to the methionine content of the protein in 0.1 M Tris/HCl at pH 8.5 and at room temperature. Reactivities of the two methionine (Met-6 and Met-8 ofthe phospholipase A2 subunit), five histidine, 14 tyrosine and one tryptophan residues of one toxin molecule with chloramine T were assessed from the change in intrinsic fluorescence and amino acid composition of the protein. Met-8 and one tyrosine on the phospholipase A2 subunit and less than one histidine were oxidized, while Met-6 remained intact after 30 min of reaction. One histidine and approx. two tyrosine residues were oxidized when both methionine residues were
INTRODUCTION
The presynaptically active toxins in snake venoms exhibit weak phospholipase A2 (PLA2) activity but are very potent in blocking neuromuscular transmission (Chang, 1985) . /,-Bungarotoxin (/%-BuTX), the main component of fl-bungarotoxins in the venom of Taiwan banded krait (Bungarus multicinctus) (Chen et al., 1982) , is a representative of this kind of toxin. The neurotoxic effect of f1-BuTX comprised a triphasic effect on cholinergic synapses (Caratsch et al., 1981) . The early biphasic effects are associated with a change in the nerve-terminal membrane as a result of a PLA2-independent interaction between the toxin and its receptor. Next, there is an effect involving the hydrolysis of phospholipid in the membrane surrounding the bound toxins. Apparently, the ability of toxins to bind to their receptors plays a crucial role in evoking the serial actions which first induce facilitation and irreversible disruption of acetylcholine release from cholinergic synapses before disruption of neuromuscular transmission. Since the action is very specific and unique, /%-BuTX has been exploited as an important tool in physiological, biochemical and pharmacological studies.
3,1-BuTX is composed of two subunits linked by a disulphide bond (Kondo et al., 1978) . One is a PLA2 subunit having 120 amino acid residues, which shows remarkable structural similarity to other vertebrate PLA2 enzymes (Kini and Evans, 1987) . The other is a rather small subunit with 60 amino acid residues. This subunit shows sequence similarity to dendrotoxin and toxins I and K from mamba venoms, which are representative of Kunitz protease inhibitors (Dufton, 1985) and themselves show facilitation of transmitter release, interference with the binding of 81-BuTX in chick muscle, and enhancement of the presynaptic effect of crotoxin and notexin (Harvey and Karlsson, 1982 Chemical modfflcation of /11-BuTX Ih1-BuTX was isolated from venom on a CM-Sephadex C-25 column (Chen et al., 1982) and purified further on a Sephadex G-50 column (Lin et al., 1984) . It was cleaved with CNBr according to our previously described method (Chu and Chen, 1991) . Finally, the reaction mixture was dialysed against water to remove reagent and small peptide fragments. /l3-BuTX was oxidized with chloramine T by a modified method of Shechter et al. (1975) . In 0.5 ml of 0.1 mM Tris/HCl at pH 8.5, 1 mg of toxin was reacted with a 100-fold molar excess of chloramine T with respect to the methionine content of the protein. The chloramine T-modified toxins obtained from desalting the reaction mixture on a PD-10 column (1.5 cm x 5.0 cm) in 0.07 M ammonium bicarbonate buffer at pH 8.0 are named CMT. The gel-filtration chromatography was completed within 5-10 min. The reaction times, given in minutes, are denoted by Abbreviations used: /81-BuTX, fl1-bungarotoxin; CMT, chloramine T-modified /81-bungarotoxins; PLA2, phospholipase A2; PVDF, poly(vinylidene difluoride).
I To whom all correspondence should be addressed. subscripts: CMTo are the control samples and CMT30 and CMT90 represent the modified toxins from 30 and 90 min of reaction respectively. The histidine, methionine or tyrosine content of the proteins was determined from direct analysis of amino acid composition (Spackman et al., 1958) . Subtraction of the amino acid content of the modified toxin from that of the parent toxin gave the amount of amino acid that was oxidized by chloramine T.
The two subunits of both fl,-BuTX and CMT30 were resolved by SDS/PAGE on a 15 % (w/v) polyacrylamide slab gel (7 cm x 9 cm) in Tricine buffer at pH 8.9 according to the method of Schagger and von Jagow (1987) . The electrophoresis was conducted at 100 V for 2 h. The polypeptides on the gel were transferred to poly(vinylidene difluoride) (PVDF) membrane (Millipore) by a diffusion method (Bowen et al., 1980) . Each polypeptide on the filter was hydrolysed in the vapour phase of 7.0 M HCl containing 10 % (v/v) trifluoroacetic acid and 0.1 % phenol at 158°C for 45 min, according to the method of Tsugita and Scheffier (1982) (C. S. Liu, personal communication) and its amino acid composition determined.
Transformation of methionine to methionine sulphoxide was assayed according to the method of Shechter et al. (1975) . Briefly, protein was cleaved with CNBr according to the method of Gross and Withop (1962) . The reaction mixture was subjected to gel filtration on a PD-10 column to remove the reagent and the small peptide fragment. The CNBr-cleaved protein was reduced with dithiothreitol before the determination of its methionine content, which represented the CNBr-resistant methionine that had been oxidized to methionine sulphoxide.
Assay of PLA2 activity and toxicity fl1-BuTX released the fatty acid from 10 ,umol of egg phosphatidylcholine suspended in 4 ml of 5 mM deoxycholate at 37 'C. The amount of fatty acid was measured by H' titration, using a Radiometer pHM8 standard pH meter attached to a T80 titrator and an ABU80 autoburette. One unit of PLA2 activity was defined as the amount of enzyme needed for the release of 1 ,uequiv. of fatty acid from phospholipid/min.
Indirectly evoked contraction of the neuromuscular preparation
The cervicis-nerve-muscle preparation was isolated from baby chicken biventer. The organ bath contained 10 ml of Tyrode's solution: NaCl, 137 mM; KCl, 2.7 mM; CaCl2, 2.8 mM; MgCl2, 1.0 mM; NaH2PO4, 0.36 mM; NaHCO3, 12.0 mM; glucose, 11.0 mM. The twitch response of biventer cervicis muscle at 37 'C was evoked by a supramaximal indirect stimulation of 0.2 Hz and the force displacement was measured isometrically with a driver amplifier (Grass polygraph D.C. model RPS 7C8).
Measurement of fluorescence
The concentration of fl1-BuTX was determined from absorbance at 280 nm, by using a value for Alcm of 12.5 (Lin et al., 1984) . The fluorescence intensity, expressed in arbitrary units, was measured at room temperature with a Hitachi F-4000 fluorescence spectrophotometer. Both the excitation and the emission slit-widths were 10 nm. Raman emission due to the scattering of solvent was minimized by adjusting the intensity scale. It took no more than 5 min to scan a spectrum, avoiding protein denaturation. FA2 represents the fluorescence intensity at wavelength A2 (nm) when the fluorophore was excited at wavelength A1 (nm).
Analysis of fluorescence data
The modified Scatchard plot (Epstein et al., 1974) 
RESULTS

Chloramine T oxidation of fl1-BuTX
Chloramine T is able to oxidize methionine, cysteine, histidine, tyrosine and tryptophan residues of proteins; however, the oxidation of the aromatic amino acids can be suppressed at alkaline pH values (Shechter et al., 1975) . ,l1-BuTX contains five histidines, two methionines (Met-6 and Met-8 of the PLA2 subunit), 14 tyrosines and one tryptophan residue (Trp-19 of PLA2 subunit) (Kondo et al., 1978) . We searched for suitable experimental conditions for the chloramine T oxidation of /hlBuTX which would oxidize the methionine residues but suppress the reactivity of the aromatic residues. Figure 1 displays the emission spectra of f,i-BuTX and the chloramine T-modified toxins (see the method for their preparation in the Experimental section) in 0.02 M Pipes buffer at pH 7.6. When excited at 275 nm, CMT,0 shared with fl-BuTX a nearly identical shoulder in the range of 300-310 nm and a 339 nm peak of similar shape but lower fluorescence intensity (Figure la) . The shoulder results from tyrosine residues that do not transfer their resonance energy to Trp-19 and the main peak arises from Trp-19, which is excited directly with absorption energy or indirectly through resonance-energy transfer from the proximal tyrosine residues (Chu and Chen, 1991) . Both proteins gave a single peak at 339 nm when they were excited at 295 nm, although fl-BuTX showed a stronger intensity than CMT,0 (Figure lb) . We recovered the modified toxins from the reaction mixture of chloramine T and f,i-BuTX by gel chromatography on a PD-10 column with an alkaline solution instead of the acidic solution which was used previously (Chang and Yang, 1988) . This was critical, as we found that the main fluorescence peak disappeared when CMT30 was recovered from an acidic solution (Figure 1 ). remained around 85 % of F2373 and 76% of F2359 of the parent toxin. These fluorescence characteristics suggested that: (a) tyrosine residues distant from Trp-19 remained intact during the chloramine T oxidation; (b) Trp-19 and its proximal tyrosine residues reacted only very slightly with chloramine T in the reaction before 30 min; however, they might be partially oxidized with longer reaction. Figure 3 displays the reactivity of the histidine, methionine and tyrosine residues on /1-BuTX with chloramine T. These three kinds of amino acids remained almost intact in CMTo.
Oxidation of both tyrosine and histidine was not extensive under the experimental conditions suitable for methionine oxidation. Reaction time (min) Figure 3 The chloramine T-reactive amino acid residues on fl1-BuTX
The chloramine T oxidation of histidine (U), methionine (A) or tyrosine (0) residue(s) on one fi1-BuTX molecule was determined as described in the text.
further by SDS/PAGE (Figure 4 ). After the polypeptides were transferred to PVDF membrane and hydrolysed, the tyrosine or histidine content of each polypeptide was determined (see the Experimental section). We determined contents of approx. 8.7 tyrosine and 2.6 histidine residues for the PLA2 subunit of CMT30, and approx. 3.9 tyrosine and 1.7 histidine for the non-PLA2 subunit of CMT30. In comparison with ,l1-BuTX, which contains ten tyrosine and three histidine residues in its PLA2 t Data from our previous study (Chu and Chen, 1991) . subunit and four tyrosine and two histidine residues in its non-PLA2 subunit (Kondo et al., 1978) , one tyrosine on the PLA2 subunit was apparently oxidized while all of the tyrosine residues of the non-PLA2 subunit remained intact in the CMT30 molecule.
However, we were unable to locate unequivocally the chloramine T-oxidized histidine on CMT30 from the histidine content data.
With regard to which one of the two methionine residues was oxidized at 30 min, one possibility was that Met-6 remained intact and Met-8 was transformed to a sulphoxide derivative, or vice versa. Modification of CMT30 with CNBr would delete from the protein molecule a hexapeptide from the N-terminus, up to Met-6 in the former situation, or an octapeptide from the Nterminus, up to Met-8 in the latter situation, considering that methionine reacts with CNBr while methionine sulphoxide is resistant. Since we determined a content of one methionine sulphoxide per molecule of the CNBr-cleaved CMT30 (see the Experimental section), the former situation was most likely to occur.
Functional characterization of CMT Using our previous method, which was able to identify the two distinct Ca2+-binding sites on /,3-BuTX molecule (Chu and Chen, 1991) , we analysed the fluorescence data obtained when Ca2+ was added to /,3-BuTX, CMTO, CMT30, or CMT90 in 0.02 M Pipes at pH 7.6 according to eqn. (1). The modified Scatchard plot for the effect of Ca2+ on F2393,9 showed the characteristics of the highaffinity site and that for the effect of Ca2+ on F23,0,5 the low-affinity site. Each protein gave a linear curve for both the high-affinity site and the low-affinity site ( Figure 5 ). The association constant determined for either site on each protein had the same order of magnitude, despite the fact that the order of the binding strengths was CMT90 < CMT30 < CMTo < /,i-BuTX (Table 1) . Apparently, the chloramine T oxidation modified ,#,-BuTX so that it became less effective at Ca2+ binding, but oxidation did not disintegrate the two Ca2+-binding sites, even when the reaction had proceeded for 90 min.
PLA2 activity and LD50 values of five proteins were compared (Table 1) . fl1-BuTX showed weak PLA2 activity but very potent toxicity. Its enzymic activity in 10 mM CaC12 at 37°C was 115 units/mg of protein and its LD50 was assayed to be 0.017 ,tg/g body weight of mice. CMTo was as potent for both activities as ,/1-BuTX. Both CMT30 and CMT90 were not lethal, even when a dose as high as 2.0 ,ug/g body weight of mice was tested. However, they showed PLA2 activity, although they were less active than ,/1-BuTX. CMT30 and CMT90 maintained approx.
65 % and 40 % of the enzymic activity of fi1-BuTX respectively. were potent, although CMTo showed slightly less ability than /J1-BuTX to block the twitch response. In a similar manner to that observed in previous work (Chang, 1985) , both proteins exhibited early biphasic presynaptic effects including an immediate depression and a restoration period of neuromuscular transmission over the first 5.0 min of action before a later phase of neuromuscular blockage (Figures 6a and 6b ). fl1-BuTX took 24 min to inhibit completely the indirectly evoked contraction of biventer cervicis muscle, while CMTo took 30 min. The early biphasic effects were not evident in the action of either CMT30 or CMT90 and they showed very little ability to evoke late-phase neuromuscular blockage. They both took more than 60 min to block the neuromuscular transmission completely (Figures 6c and 6d) . The time only shortened slightly to 56 min even when CMT30or CMT90 concentrations were increased to 0.45 ,csM in the organ bath (results not shown). Moreover, CNBr-modified /,%-BuTX showed no neuromuscular blocking activity over the time period tested (Figure 6e ).
DISCUSSION
Vertebrate PLA2 enzymes share a very similar tertiary structure (Keith et al., 1981; Dijkstra et al., 1983; White et al., 1990) . In the /,%-BuTX molecule the rather hydrophobic NLINF-MEMIRYT segment of the N-terminal region of the PLA2 subunit forms a helix whose steric arrangement in the protein molecule is dominated by the confinement of Asn-l that is stabilized by Asn-4, Gln-67 and a hydrogen-bonded network involving His-48, Try-52, Pro-63, Try-68 and Asp-94 (Chu and Chen, 1991) . Met-6 and Met-8 are in the same helical turn, although the environment around Met-6 differs from that of Met-8; note that the side chains of Leu-2, Met-6 and Arg-10 are on one side and those of are on the opposite side of the helical core. We found that selective modification of the two methionine residues could be achieved by controlling the reaction time for the chloramine T oxidation offl1-BuTX in alkaline solution under which conditions oxidation of the aromatic residues was limited but could not be suppressed completely (Figure 3) .
The c.d. characteristics of fl-BuTX suggest a stable tertiary structure of the protein molecule in a segmental sense, and 80 % of the helical structure of J,1-BuTX remains in CNBr-modified fl1-BuTX, in which a helical segment of octapeptide is deleted from the N-terminal region of the PLA2 subunit (Chu and Chen, 1991) . In line with the evidence that the chloramine T oxidation of /l-BuTX did not disintegrate its two Ca2+-binding domains (Table 1) , CMT30 may remain in the gross conformation of /11-BuTX. We confirmed that the chloramine T-reactive amino acid residues, including mainly Met-8 and one tyrosine, are on the PLA2 subunit of CMT30, suggesting that its non-PLA2 subunit may remain intact. Together with the functional characteristics of CMT30, this suggests that these two residues on the PLA2 subunit have an essential role in the PLA2-independent neurotoxic effect of /,)-BuTX. However, one should not neglect the importance of the non-PLA2 subunit, which may interact with the PLA2 subunit in the maintenance of the active conformation needed for the neurotoxic effect (Lin et al., 1984; Chu and Chen, 1991) or/and may itself cause a presynaptic effect as suggested previously (Harvey and Karlsson, 1982) .
Met-6 was not oxidized, but Met-8 was transformed to a sulphoxide derivative in the CMT30 molecule. According to the results of a spectrophotometric titration for the tyrosine residues of/%l-BuTX (Yang and Lee, 1986) , there are only three 'exposed' residues which can be titrated at pH values lower than 10.5. Most of the tyrosine residues are 'buried' in or confined on the protein molecule since they are titratable only at pH values higher than 11.0. Chemical modification of /1-BuTX with tyrosine-specific reagents, which should most likely occur at the exposed residues, may not lead to the inactivation of /,1-BuTX as suggested in previous studies: (a) iodination of fl1-BuTX with Na125I, by either the lactoperoxidase or the chloramine T method, shows no significant effect on the toxicity and the binding affinity of /,1-BuTX (Rehm and Betz, 1982; Tzeng et al., 1989) ; (b) selective sulphonation of Tyr-68 (pKa = 10.1) of the PLA2 subunit by pnitrobenzenesulphonyl fluoride makes the modified toxin more potent in both its enzymic activity and the induction of indirectly evoked contraction of the phrenic nerve diaphragm preparation, though it results in a partial decrease in lethal potency when compared with the activities of the parent toxin (Rosenberg et al., 1989) . These findings, together with the present results, imply that oxidation of Met-8 may be the primary cause of the loss of neurotoxic effect by CMT30.
There are two binding sites for calcium ions on different domains of the PLA2 subunit of /,%-BuTX Chen, 1989, 1991) . The high-affinity-site domain is associated with the catalytic site for phospholipid hydrolysis. The low-affinity-site domain is involved, in the presence of Ca2 , in the interaction process with micellar lipid/water. This is the first step in the catalysis of PLA2 and the N-terminal region is believed to be part ofthe so-called interface recognition site for this process. Removal of the N-terminal octapeptide of the PLA2 subunit disintegrates the Ca2+-binding domain of the low-affinity site but does not disrupt that of the high-affinity site (Table 1) . CNBr-modified fl1-BuTX is not lethal and shows neither the enzymic activity nor the ability to elicit the indirectly evoked contraction of a neuromuscular preparation (Table 1 active site other than the two Ca2l-binding domains and is required for a PLA2-independent interaction with the nerve terminal membrane, which occurs before the hydrolysis of the membrane phospholipid during the neurotoxic effect of #,-BuTX (Caratsch et al., 1981) . The chloramine T oxidation of Met-8 may effect a reduction of hydrophobicity or dipole moment of the N-terminal region, in addition to a conformational change that results in a partial decrease of the PLA2 activity offl1-BuTX. Both of these physical properties are thought to make an important contribution to the neurotoxicity of the PLA2 neurotoxin family (Tsai et al., 1987) . It is unclear whether Met-8 binds directly to the f,i-BuTX receptor, which is suspected to be a
